Contraste
Acessibility 
Average Target Price – R$ 4,21
| Consensus | 2025E | 2026E |
|---|---|---|
| Net sales (R$ million) | R$ 29,164 | R$ 30,609 |
| Gross margin (%) | 30.9% | 31.4% |
| Adjusted EBITDA (R$ million) | R$ 2,522 | R$ 2,769 |
| Financial result (R$ million) | -R$ 2,036 | -R$ 1,901 |
| Net income (R$ million) | -R$ 1,130 | -R$ 659 |
TARGET PRICE (Sell) – R$ 3,80
| Banco do Brasil projections | 2025E | 2026E |
|---|---|---|
| Net sales (R$ million) | R$ 28,617 | R$ 30,336 |
| Gross margin (%) | 29.3% | 30.9% |
| Adjusted EBITDA (R$ million) | R$ 2,075 | R$ 2,230 |
| Financial result (R$ million) | R$ (2,540) | R$ (2,509) |
| Net income (R$ million) | R$ (1,095) | R$ (1,008) |
TARGET PRICE (Sell) – R$ 3,00
| BofA Merrill Lynch projections | 2025E | 2026E |
|---|---|---|
| Net sales(R$ million) | R$ 29,213 | R$ 30,217 |
| Gross margin (%) | – | – |
| Adjusted EBITDA (R$ million) | – | – |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | -R$ 1,546 | -R$ 969 |
TARGET PRICE (Neutral) – R$ 9,00
| Bradesco projections | 2024E | 2025E |
|---|---|---|
| Net sales (R$ million) | R$ 30,512 | R$ 32,209 |
| Gross margin (%) | – | – |
| Adjusted EBITDA (R$ million) | R$ 3,008 | R$ 3,207 |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | – | R$ 44 |
TARGET PRICE (Neutral) – R$ 3,00
| BTG Pactual projections | 2025E | 2026E |
|---|---|---|
| Net sales(R$ million) | R$ 28,637 | R$ 30,108 |
| Gross margin (%) | 31.6% | 32.1% |
| Adjusted EBITDA (R$ million) | R$ 2,561 | R$ 2,859 |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | -R$ 754 | -R$ 154 |
TARGET PRICE (Neutral) – R$ 4,00
| Genial projections | 2025E | 2026E |
|---|---|---|
| Net sales(R$ million) | R$ 29,715 | R$ 30,509 |
| Gross margin (%) | 31.1% | 31.6% |
| Adjusted EBITDA (R$ million) | R$ 2,692 | R$ 2,933 |
| Financial result (R$ million) | -R$ 2,326 | -R$ 2,141 |
| Net income (R$ million) | -R$ 602 | -R$ 327 |
TARGET PRICE (Sell) – R$ 3,20
| Goldman Sachs projections | 2025E | 2026E |
|---|---|---|
| Net sales (R$ million) | R$ 29,193 | R$ 30,891 |
| Gross margin (%) | – | – |
| Adjusted EBITDA (R$ million) | R$ 2,496 | R$ 2,689 |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | -R$ 1,462 | -R$ 1,200 |
TARGET PRICE (Sell) - -
| Morgan Stanley projections | 2025E | 2026E |
|---|---|---|
| Net sales(R$ million) | R$ 28,963 | R$ 30,759 |
| Gross margin (%) | 30.9% | 31.0% |
| Adjusted EBITDA (R$ million) | R$ 2,290 | R$ 2,469 |
| Financial result (R$ million) | -R$ 3,279 | -R$ 2,953 |
| Net income (R$ million) | -R$ 1,418 | -R$ 1,116 |
TARGET PRICE (Sell) – R$ 4,00
| Safra projections | 2025E | 2026E |
|---|---|---|
| Net sales (R$ million) | R$ 28,949 | R$ 30,322 |
| Gross margin (%) | – | – |
| Adjusted EBITDA (R$ million) | R$ 2,502 | R$ 2,788 |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | -R$ 1,143 | -R$ 675 |
TARGET PRICE (Neutral) – R$ 3,90
| Santander projections | 2025E | 2026E |
|---|---|---|
| Net sales(R$ million) | R$ 28,674 | R$ 30,126 |
| Gross margin (%) | 31.5% | 31.5% |
| Adjusted EBITDA (R$ million) | R$ 2,552 | R$ 2,976 |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | – R$ 1,020 | – R$ 527 |
TARGET PRICE (Neutral)) – R$ 4.00
| XP projections | 2025E | 2026E |
|---|---|---|
| Net sales(R$ million) | – | – |
| Gross margin (%) | – | – |
| Adjusted EBITDA (R$ million) | – | – |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | – | – |
